Amantadine recalls

The FDA has published 6 recalls involving Amantadine since 2017. The latest was reported on 4 Mar 2026. Most were for potency & assay. AvKARE has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls6since 2017
Last 12 months1reported
Class I00% of total
Ongoing2latest 4 Mar 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 6 100%Class III 0 0%

By year

Ongoing amantadine recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine HclAvKAREPotency & AssayNationwide
DrugCLASS IIAmantadine Hydrochloride Oral Solution USP, 50mg recalled by AkornAkornPotency & AssayNationwide

All amantadine recalls, newest first

6 total

Should you stop taking Amantadine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.